Both increased EGFR activation and overexpression, most often resulting from somatic mutations, gene amplification, transcriptional upregulation, or ligand overproduction, promote cancer development and progression, including tumor angiogenesis, metastasis, and resistance to apoptosis [4,5]. This evidence concerns the gene EGFR and neoplasm.